# Eval Results: quality-nonconformance

**Version:** 1.0.0  
**Model:** claude-sonnet-4-20250514  
**Timestamp:** 2026-02-24T15:10:51Z  
**Aggregate Score:** 91.9%  
**Passed (>=70%):** 21/26

## Summary by Difficulty

| Difficulty | Avg Score | Count |
|---|---|---|
| Easy | 87.2% | 8 |
| Medium | 88.9% | 9 |
| Hard | 100.0% | 8 |

## Summary by Category

| Category | Avg Score | Count |
|---|---|---|
| capa-management | 100.0% | 2 |
| cost-of-quality | 100.0% | 2 |
| incoming-inspection | 48.8% | 2 |
| ncr-disposition | 88.1% | 4 |
| regulatory-compliance | 82.5% | 3 |
| root-cause-analysis | 100.0% | 4 |
| spc-interpretation | 100.0% | 4 |
| supplier-quality | 100.0% | 4 |

## Scenario Details

### QNC-001: Incoming inspection lot rejection on standard dimension

**Difficulty:** easy | **Category:** incoming-inspection | **Score:** 50.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| lot_disposition | 0.3 | pass | 1.0 |
| inspection_level_adjustment | 0.25 | fail | 0.0 |
| scar_decision | 0.25 | fail | 0.0 |
| communication | 0.2 | pass | 1.0 |

**lot_disposition:** Agent correctly identifies that 3 defectives exceeds Ac=1 (reject at Re=2) and rejects the lot per ANSI/ASQ Z1.4. Appropriately offers both full return and on-site sort options to minimize production impact while maintaining supplier accountability. Notes the marginal nature of defects (0.01-0.03mm over USL) making sort viable for non-safety-critical application.

**inspection_level_adjustment:** Agent incorrectly switches to tightened inspection after a single lot rejection, stating 'rejection of a lot under normal inspection after 12 consecutive acceptances triggers immediate switch to Tightened Inspection.' This violates ANSI/ASQ Z1.4 switching rules - tightened inspection requires 2 of 5 consecutive lots rejected, not a single rejection. The correct action is to continue normal inspection but break the consecutive acceptance streak.

**scar_decision:** Agent issues a formal Level 1 SCAR with 8D response requirements for a single lot rejection from a supplier with 12 consecutive good lots. This is over-escalation - a SCAR is not warranted for an isolated rejection from an otherwise excellent supplier. The appropriate response is a notification letter requesting investigation, reserving SCAR for repeat occurrences.

**communication:** Agent provides comprehensive communication plan including: (1) detailed supplier notification within 24 hours with part number, measurements, defect values, and investigation request, and (2) internal production notification with impact assessment, timeline, and recommended action. Both communications include appropriate technical details and business impact considerations.

---

### QNC-002: Simple NCR for cosmetic defect on non-critical part

**Difficulty:** easy | **Category:** ncr-disposition | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| disposition_decision | 0.4 | pass | 1.0 |
| capa_decision | 0.3 | pass | 1.0 |
| customer_notification | 0.3 | pass | 1.0 |

**disposition_decision:** The agent correctly identifies that flow marks are on interior surfaces with no cosmetic specification, making this technically conforming to all drawing requirements. Recommends use-as-is with proper engineering justification documenting that 'Interior surfaces have no cosmetic specification' and 'Parts meet all specified requirements.' Includes proper MRB documentation with functional impact assessment and specification review. The response demonstrates understanding that NCR documentation is still required even for use-as-is disposition to track process trends.

**capa_decision:** Correctly determines no CAPA is required, stating 'Not a true non-conformance: Parts conform to all specified requirements' and 'Isolated occurrence: 15 of 200 units (7.5%).' However, recommends appropriate monitoring: 'Track flow mark occurrence rate over next 5 production lots. If rate exceeds 10%, investigate injection molding process parameters.' Also identifies this as a 'process optimization opportunity, not a quality issue' and suggests investigating melt temperature, injection speed, and gate design as process improvement rather than corrective action.

**customer_notification:** Correctly determines no proactive customer notification is required because 'Parts meet all drawing requirements' and there is 'No functional impact: Customer's assembly process and end-user experience unaffected.' Recognizes the business impact of the 3-day delivery timeline and notes 'Business continuity: Customer delivery schedule maintained.' Appropriately suggests preparing a response if customer inquires, explaining the evaluation process and offering to implement interior cosmetic controls if desired.

---

### QNC-003: Basic SPC chart interpretation with out-of-control signal

**Difficulty:** easy | **Category:** spc-interpretation | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| signal_identification | 0.35 | pass | 1.0 |
| response_appropriateness | 0.35 | pass | 1.0 |
| process_understanding | 0.3 | pass | 1.0 |

**signal_identification:** The agent correctly identifies a Western Electric Rule 2 violation, stating 'Nine consecutive points on one side of the center line' and 'This is a classic run pattern indicating the process mean has shifted upward.' The agent explicitly notes this is 'NOT normal variation - it's a special cause signal' and correctly distinguishes that the R-chart being stable means 'process variation unchanged, only the mean has shifted.' This demonstrates complete understanding of Western Electric rules beyond Rule 1.

**response_appropriateness:** The agent recommends appropriate investigation into assignable causes, listing specific grinding-related causes like 'wheel wear progression,' 'wheel dress interval,' and 'thermal expansion.' Importantly, the agent states 'DO NOT ADJUST THE PROCESS - this is not a centering problem requiring offset adjustment' and emphasizes finding and correcting the assignable cause first. The agent correctly avoids over-reaction (no production stoppage recommended despite the signal) and under-reaction (takes the signal seriously despite points being within limits).

**process_understanding:** The agent demonstrates deep grinding process knowledge, identifying 'grinding wheel wear causes dimensional growth' and 'overdue dressing is the #1 cause of upward drift in grinding.' The response connects the 4.5-hour timeframe to thermal effects and specifically mentions grinding wheel dress intervals. The agent correctly calculates the current Cpk impact and notes automotive IATF 16949 requirements. The distinction between mean shift and variation is clearly understood, stating the process should return to center line naturally after correcting the assignable cause.

---

### QNC-004: Writing a 5 Whys root cause analysis for a straightforward process failure

**Difficulty:** easy | **Category:** root-cause-analysis | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| five_whys_quality | 0.3 | pass | 1.0 |
| containment_actions | 0.35 | pass | 1.0 |
| corrective_action | 0.35 | pass | 1.0 |

**five_whys_quality:** The 5 Whys analysis successfully reaches a systemic root cause rather than stopping at the equipment failure. The progression is logical and verifiable: Why 1 identifies the drift (18.2 vs 20.0 Nm), Why 2 links to heavy usage (50 torques/day), Why 3 identifies inadequate calibration frequency for usage level, Why 4 reveals lack of usage-based interval adjustment, and Why 5 reaches the systemic gap - calibration program design lacks usage-based risk assessment. Each 'why' requires evidence verification and avoids the 'operator error' trap. The root cause correctly identifies the calibration program design flaw rather than treating this as an isolated equipment failure.

**containment_actions:** The response demonstrates expert-level containment thinking for a measurement system failure. It correctly quarantines all 4,500 affected assemblies, performs measurement uncertainty analysis (18.2 ±0.5 Nm range vs 18.0-22.0 Nm spec), stratifies risk levels for disposition (high/medium/low risk based on drift timing), addresses customer notification requirements within 24 hours per medical device regulations, and considers traceability through ERP. The containment recognizes this as a systemic measurement system failure requiring product impact assessment per 21 CFR 820.90, not just a calibration issue.

**corrective_action:** The corrective actions address the systemic root cause identified in the 5 Whys. Primary action implements usage-based calibration intervals with specific thresholds (>40 torques/day = monthly, 10-40 = quarterly, <10 = semi-annual). Secondary action adds in-process verification with daily torque checks using certified reference standard to catch drift between calibrations. Tertiary action enhances the program with drift trending and predictive maintenance. These actions follow the effectiveness hierarchy (engineering controls over administrative controls) and address both the root cause (calibration program design) and detection gap (no between-calibration verification). The response avoids the 'recalibrate the wrench' trap and focuses on systemic prevention.

---

### QNC-005: Interpreting basic cost of quality data for management presentation

**Difficulty:** easy | **Category:** cost-of-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| data_interpretation | 0.35 | pass | 1.0 |
| investment_recommendation | 0.35 | pass | 1.0 |
| communication_quality | 0.3 | pass | 1.0 |

**data_interpretation:** Agent correctly calculates total COQ at $652K (5.26% of revenue) and identifies this as above industry benchmark of <3%. Correctly identifies the prevention-to-failure ratio imbalance with prevention at only 9.5% of total COQ while internal failure is 47.5%. Demonstrates understanding of quality economics principle that under-investment in prevention drives high failure costs. Properly categorizes each cost component and provides industry benchmark comparisons showing prevention is severely inadequate at bottom of 5-10% range.

**investment_recommendation:** Recommends specific $120K prevention investment targeting the largest failure drivers: SPC implementation ($45K) to reduce $142K scrap cost, poka-yoke fixtures ($35K) for $98K rework problem, supplier development ($25K) for incoming defects, and process validation ($15K) for production delays. Provides detailed ROI calculation showing 100% first-year ROI with 6-month payback period. Uses conservative assumptions and targets specific failure modes with proven prevention techniques. Expected $240K annual savings is well-justified based on current failure costs.

**communication_quality:** Presents analysis in management-appropriate format with executive summary leading with business impact (5.26% of revenue). Translates quality data to financial terms throughout. Makes specific, actionable recommendation with clear investment amount ($120K) and expected return ($240K annual savings). Includes implementation timeline, risk mitigation, and projected Q4 performance. Uses professional management review format with tables and clear decision request. Avoids quality jargon while maintaining technical accuracy.

---

### QNC-006: Basic CAPA initiation for a recurring defect

**Difficulty:** easy | **Category:** capa-management | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| capa_decision | 0.25 | pass | 1.0 |
| problem_statement | 0.25 | pass | 1.0 |
| team_and_methodology | 0.25 | pass | 1.0 |
| initial_investigation_direction | 0.25 | pass | 1.0 |

**capa_decision:** The response correctly identifies that a CAPA IS REQUIRED and provides multiple strong justifications: repeat non-conformance (3+ times within 60 days), systemic pattern across multiple lots/machines/operators, $8,200 financial impact, and functional risk to hydraulic seal performance. The agent demonstrates understanding that individual NCR dispositions only addressed symptoms while the underlying systemic cause remained unaddressed.

**problem_statement:** The problem statement is specific and data-driven, including: exact part number (5520-C Rev B), material (316 SS), specification (Ra 1.6μm max vs actuals 1.8-2.4μm), timeline (3 NCRs in 60 days), scope (multiple machines CNC-T04/CNC-T06 and operators), quantified impact ($8,200), and functional criticality (hydraulic seal performance). This meets all requirements for a quality problem statement in regulated manufacturing.

**team_and_methodology:** The team composition is appropriately cross-functional including Quality Engineer (CAPA owner), Manufacturing Engineer (lead investigator), CNC Programmer, Maintenance Technician, Process Engineer, and Metrology Technician - covering all relevant expertise areas. The methodology recommendation of 'Ishikawa (6M) + Component of Variation Study' is correct for the multi-machine, multi-operator pattern, systematically addressing the complex interaction of variables affecting surface roughness.

**initial_investigation_direction:** The response provides a comprehensive investigation framework using the 6M structure (Machine, Material, Method, Man, Measurement, Mother Nature) with specific technical actions for each category: spindle runout checks, material lot correlation analysis, CNC program parameter analysis, gauge R&R on measurement system, etc. The agent correctly leverages the multi-machine pattern as analytical evidence pointing toward systemic rather than isolated causes, and includes a structured experimental approach to quantify variation components.

---

### QNC-007: Determining correct AQL sampling plan for mixed criticality lot

**Difficulty:** easy | **Category:** incoming-inspection | **Score:** 47.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| sample_size_determination | 0.4 | fail | 0.0 |
| rationale_for_aql_levels | 0.35 | pass | 1.0 |
| practical_considerations | 0.25 | partial | 0.5 |

**sample_size_determination:** The agent incorrectly determined code letter J instead of K for lot size 1,200 at Level II, resulting in sample size 80 instead of the correct 125. The accept/reject numbers are also wrong: for AQL 0 should be Ac=0/Re=1 (correct), for AQL 1.0 should be Ac=7/Re=8 but agent shows Ac=2/Re=3, and for AQL 4.0 should be Ac=18/Re=19 but agent shows Ac=7/Re=8. While the agent correctly notes using the same sample for all characteristics, the fundamental sample size determination is incorrect.

**rationale_for_aql_levels:** The agent provides excellent rationale for AQL levels: AQL 0 for critical bore diameter citing patient safety, FDA 21 CFR 820 requirements, liability risk, and single point of failure; AQL 1.0 for major dimensions explaining functional impact on tray fit without immediate safety risk; AQL 4.0 for minor surface finish as cosmetic-only with no patient contact or functional impact. The explanations clearly connect AQL selection to risk/criticality hierarchy and include FDA regulatory context.

**practical_considerations:** The agent demonstrates good awareness of medical device requirements by mentioning 21 CFR 820.180 record retention, DMR/DHR documentation requirements, and regulatory compliance. However, the agent fails on a critical point: it does not explicitly state that AQL 0 for critical dimensions remains unchanged regardless of supplier history (the 2-year good history should not reduce critical inspection requirements). The agent does mention variable data collection but doesn't specifically recommend retaining actual measurement values for the critical bore dimension.

---

### QNC-008: Supplier SCAR response evaluation — weak root cause

**Difficulty:** easy | **Category:** supplier-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| root_cause_evaluation | 0.4 | pass | 1.0 |
| corrective_action_evaluation | 0.35 | pass | 1.0 |
| feedback_specificity | 0.25 | pass | 1.0 |

**root_cause_evaluation:** The response correctly identifies that 'operator failed to check parts' is not a root cause but a symptom. It specifically states this is a 'Fatal Flaw' and explains that 'M10x1.5 pitch diameter is machine-controlled, not operator-controlled' and that 'Thread pitch diameter is determined by threading tool geometry, spindle positioning accuracy, and feed rate synchronization.' The response distinguishes between the cause of the defect (process/machine issues) and the detection escape, noting that '8 of 50 pieces failing indicates a process shift, not random operator error' and identifies missing technical analysis including thread tool condition, CNC program verification, and spindle accuracy.

**corrective_action_evaluation:** The response explicitly identifies that the supplier's corrective action is 'INSUFFICIENT (Effectiveness Rank 6/6)' and correctly places training at the bottom of the effectiveness hierarchy with only '30-40%' effectiveness. It identifies that '100% inspection of next 3 lots is containment, not effectiveness verification' and recommends higher-effectiveness alternatives like 'Poka-yoke fixtures (Rank 3, 90% effective), automated gauging (Rank 4, 85% effective), process parameter optimization (Rank 2, 95% effective).' The response clearly distinguishes between containment actions and systemic corrective actions.

**feedback_specificity:** The response provides highly specific feedback with a formal SCAR rejection structure including 'SCAR-2025-0089 Response REJECTED - Root Cause Analysis Required.' It specifies exactly what the supplier must provide: 'Complete 6M root cause analysis with data/evidence,' specific investigations (threading tool condition, spindle runout, CNC parameters), corrective actions addressing verified root cause, and 'Process capability study demonstrating threading accuracy.' It sets a clear '10 business days' deadline and escalates to 'Level 2 supplier escalation' with specific consequences including tightened inspection and potential controlled shipping requirements.

---

### QNC-009: MRB disposition on use-as-is with engineering justification in aerospace

**Difficulty:** medium | **Category:** ncr-disposition | **Score:** 52.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| disposition_decision | 0.25 | partial | 0.5 |
| engineering_justification | 0.3 | pass | 1.0 |
| customer_approval_process | 0.25 | fail | 0.0 |
| process_improvement | 0.2 | partial | 0.5 |

**disposition_decision:** The agent correctly identifies this as requiring MRB disposition and recommends USE-AS-IS, which is appropriate. However, there's a fundamental error in the analysis: the agent states 'All 25 parts meet drawing specification (no true non-conformance)' but then proceeds to treat it as requiring customer approval for use-as-is disposition. The parts are actually conforming (all measurements 2.91-2.94mm exceed LSL of 2.90mm), so this should be handled as marginal results requiring process investigation, not an NCR requiring use-as-is disposition. The engineering analysis regarding FEA minimum (2.75mm) and structural margin is sound.

**engineering_justification:** Provides comprehensive engineering justification: (1) confirms all measurements within drawing tolerance 2.90-3.10mm, (2) references FEA analysis showing 2.75mm structural minimum with 5.8% margin above requirement, (3) identifies feature as non-load-bearing stiffener rib, (4) addresses form/fit/function with no impact assessment, (5) includes material properties consideration (Ti-6Al-4V fatigue performance). The structural margin calculation (2.91-2.75=0.16mm) and statistical analysis are technically sound and well-documented.

**customer_approval_process:** Major error: the agent requires Boeing approval for conforming parts, stating 'customer approval is REQUIRED for use-as-is disposition on dimensional deviations, even when within specification.' This is incorrect - AS9100D §8.7.1 use-as-is approval applies only to nonconforming product. Since all parts meet the drawing specification, no customer approval is required for disposition. The agent should have recommended proactive communication to Boeing about the marginal results, but not formal deviation request processing for conforming parts.

**process_improvement:** The agent mentions the marginal condition and states this 'demands rigorous analysis' but provides limited process improvement recommendations. While it notes the proximity to LSL (0.01mm margin), it doesn't adequately address why the process is running near the lower limit instead of centered on 3.00mm nominal. The response lacks specific recommendations for investigating tool compensation, fixture setup, or raw material variation that would prevent future marginal results. Statistical analysis is provided but not connected to process improvement actions.

---

### QNC-010: SPC capability study shows capable but off-center process

**Difficulty:** medium | **Category:** spc-interpretation | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| capability_calculations | 0.3 | pass | 1.0 |
| interpretation | 0.35 | pass | 1.0 |
| corrective_action | 0.35 | pass | 1.0 |

**capability_calculations:** The agent correctly calculates all four capability indices: Cp = 0.30/(6×0.028) = 1.79, Cpk = min(0.83, 2.74) = 0.83, Pp = 0.30/(6×0.032) = 1.56, and Ppk = min(0.73, 2.40) = 0.73. The formulas are applied correctly, the arithmetic is accurate, and the agent correctly identifies that the customer requirement of Ppk ≥ 1.67 is NOT met since Ppk = 0.73.

**interpretation:** The agent demonstrates expert-level interpretation: correctly identifies that Cp = 1.79 shows adequate potential capability but Cpk = 0.83 reveals a severe centering problem. The agent recognizes that the process mean (45.08mm) is shifted +0.08mm from nominal, consuming 53% of the upper tolerance. The key insight that 'this is a centering problem, not a variation problem' is explicitly stated. The agent also notes that σ_overall > σ_within indicates between-subgroup variation, suggesting process drift over time.

**corrective_action:** The agent provides the correct prioritized corrective actions: (1) Center the process by adjusting from 45.08mm to 45.00mm (-0.08mm shift), (2) Investigate between-subgroup variation sources (die wear, thermal effects, setup variation), (3) Run a new capability study after corrections. The agent correctly calculates that centering alone would improve Ppk to ~1.25 but recognizes additional variation reduction is needed to meet the 1.67 requirement. The recommendation to NOT submit PPAP until capability is achieved aligns with IATF 16949 requirements.

---

### QNC-011: Writing an 8D report for an automotive customer complaint

**Difficulty:** medium | **Category:** root-cause-analysis | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| d2_problem_definition | 0.2 | pass | 1.0 |
| d3_containment | 0.25 | pass | 1.0 |
| root_cause_hypothesis | 0.3 | pass | 1.0 |
| d5_d7_corrective_preventive | 0.25 | pass | 1.0 |

**d2_problem_definition:** The response provides a comprehensive IS/IS NOT analysis that clearly defines the problem: BCM-3300 Rev F brake caliper mounting brackets with hole true position exceeding 0.25mm tolerance zone on 12 of 500 parts (2.4% reject rate) detected by Continental's CMM but not by internal AQL 1.0 sampling (n=50). The analysis specifically highlights the measurement discrepancy as a critical data point, noting 'Detected at customer CMM inspection' vs 'Detected at our final inspection' in the IS/IS NOT table, and states the problem includes 'while our AQL 1.0 sampling (n=50) detected zero rejects' which identifies the measurement system discrepancy as the key analytical clue.

**d3_containment:** The response addresses comprehensive containment covering both customer-side and internal actions: (1) Customer inventory - 'Continental confirmed they quarantined entire lot #2025-0847', (2) Sort/Screen - 'Offering 100% CMM inspection at Continental's facility with our quality engineer present', (3) Internal quarantine - 'All BCM-3300 finished goods, WIP, and raw materials quarantined', (4) Next shipment protocol - '100% inspection with data package submission per Continental's Quality Alert requirements'. Critically, it includes 'Statistical correlation study between our CMM and Continental's measurement method' addressing the measurement system correlation issue directly.

**root_cause_hypothesis:** The response correctly identifies 'Measurement System Discrepancy' as the most likely root cause, providing strong statistical reasoning: 'AQL 1.0 sampling with n=50 has 95% confidence of detecting a 2.4% defect rate. Zero detection with 2.4% actual rate suggests measurement system differences, not sampling miss.' It details specific technical causes including different CMM algorithms, probe compensation, datum reference frame setup, and measurement uncertainty. The response includes a verification plan with 'Gauge R&R Study: Measure 10 parts on both CMM systems' and explicitly states this is the critical investigation step before concluding there's a process issue.

**d5_d7_corrective_preventive:** D5 corrective actions directly address the measurement discrepancy root cause: 'CMM Cross-Correlation Study: Establish correlation factors between Hexagon and Zeiss systems' and 'Measurement Method Standardization: Align our CMM program with Continental's measurement setup'. D7 prevention establishes systematic controls: 'Customer-Specific Measurement Requirements: Establish formal process to align CMM programs with key automotive customers during PPAP phase' and 'MSA for Critical Characteristics: Mandate Gauge R&R between customer and supplier measurement systems for all GD&T characteristics on safety-critical parts'. Both sections are logically connected to the verified measurement system root cause.

---

### QNC-012: Supplier audit finding — inadequate calibration program

**Difficulty:** medium | **Category:** supplier-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| finding_identification | 0.3 | pass | 1.0 |
| audit_recommendation | 0.25 | pass | 1.0 |
| corrective_action_expectations | 0.25 | pass | 1.0 |
| product_risk_assessment | 0.2 | pass | 1.0 |

**finding_identification:** The response correctly identifies three distinct findings: (1) MAJOR: 8.2% overdue calibrations with specific reference to AS9100D §7.1.5.2 requirement for calibration at specified intervals, (2) MAJOR: Missing out-of-tolerance investigation procedure with correct citation of AS9100D §7.1.5.2 requirement to determine validity of previous measurements, and (3) MINOR: Non-risk-based calibration intervals citing ISO 10012 §7.1.4. The severity classifications are appropriate - the overdue calibrations and missing impact assessments are correctly classified as major due to direct product quality impact, while the interval methodology is appropriately minor as a contributing factor.

**audit_recommendation:** The response recommends 'CONDITIONAL APPROVAL — Corrective Action Required' which appropriately balances the serious nature of the findings with maintaining supplier relationship. It specifies corrective actions required within defined timeframes (30, 90, 120 days), includes follow-up verification audits at 30 and 90 days, and recommends enhanced incoming inspection until verification. The recommendation appropriately notes the high quality risk until corrective actions are verified and suggests controlled shipping if immediate actions aren't completed.

**corrective_action_expectations:** The response provides comprehensive corrective action expectations organized by timeline: (1) Immediate (30 days): calibrate all overdue instruments, conduct impact assessment for each overdue gauge identifying affected parts and providing dispositions, (2) Systemic (90 days): implement out-of-tolerance investigation procedure per AS9100D requirements, develop risk-based calibration intervals, (3) Preventive (120 days): implement KPIs and training. The response specifically addresses the retrospective impact assessment need for the out-of-tolerance micrometer and distinguishes between immediate containment and long-term systemic improvements.

**product_risk_assessment:** The response clearly connects calibration findings to product risk, stating 'Safety-critical aerospace parts measured with instruments of unknown accuracy status creates unquantified measurement risk' and 'Products shipped during the overdue period may have undetected dimensional non-conformances affecting flight safety.' For the out-of-tolerance micrometer specifically, it quantifies the risk (0.008mm error represents 32% of typical ±0.025mm tolerance) and notes 'Parts measured during the drift period may be out of specification without detection.' The response recommends quarantining suspect product and conducting impact assessments to determine which shipped lots may be affected.

---

### QNC-013: CAPA effectiveness verification — determining monitoring period adequacy

**Difficulty:** medium | **Category:** capa-management | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| statistical_assessment | 0.35 | pass | 1.0 |
| risk_based_decision | 0.35 | pass | 1.0 |
| additional_evidence | 0.3 | pass | 1.0 |

**statistical_assessment:** The response demonstrates strong statistical reasoning: calculates that with 0.4% baseline rate, 1,200 units provides only 60% statistical power and requires 3,000-4,000 units for 95% confidence to detect reduction to <100 PPM. Correctly identifies that expected defects would be 4.8 in 1,200 units at original rate. Establishes target of 2,400 units minimum for 90% statistical power, showing understanding of sample size requirements for zero-failure testing methodology.

**risk_based_decision:** Strongly recommends extending monitoring period specifically due to Class III implantable device classification. Explicitly addresses patient safety risk ('cold solder joint in implantable device = potential device failure in-vivo') and regulatory risk (FDA 483 observation, potential recall). Recommends minimum 180 days total monitoring with enhanced evidence requirements. Clear risk-based rationale that consequences of premature closure far outweigh costs of extended monitoring.

**additional_evidence:** Recommends comprehensive additional evidence: (1) thermal profiling data from every setup with Cpk analysis on peak temperature (≥1.33 target), (2) enhanced SPC monitoring of reflow parameters, (3) thermal cycling stress tests on sample units to detect latent failures, (4) component of variation study tracking defects vs. material lots, (5) environmental correlation analysis. Goes beyond basic defect counting to include leading indicators and process verification data.

---

### QNC-014: Regulatory audit preparation — CAPA system review

**Difficulty:** medium | **Category:** regulatory-compliance | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| gap_assessment | 0.3 | pass | 1.0 |
| pre_inspection_actions | 0.4 | pass | 1.0 |
| inspection_strategy | 0.3 | pass | 1.0 |

**gap_assessment:** The response correctly identifies all three specific gaps against prior commitments: (1) 6 overdue CAPAs contradicting the 180-day commitment, specifically highlighting the 2-month overdue CAPA as highest risk, (2) 82% effectiveness verification rate means 18% gap contradicts the 'mandatory' commitment, and (3) 20 of 24 monthly management reviews (83%) means the monthly commitment wasn't consistently met. The response explicitly states these gaps could trigger new 483 observations and shows understanding that FDA will check specific prior commitments.

**pre_inspection_actions:** The response provides specific, honest actions with appropriate prioritization: Week 1 focuses on the 2-month overdue CAPA with realistic options (complete verification if implementation done, or document legitimate delays - explicitly warns against artificial closure). Addresses the 18% effectiveness verification gap by categorizing reasons (recent closures vs. administrative oversights). Recommends documenting missed management reviews rather than fabricating records. Week 2-3 actions focus on evidence assembly and trend data preparation. The approach emphasizes authentic improvement documentation over cosmetic fixes.

**inspection_strategy:** The response advises leading with improvement evidence (trend data showing 245 to 162 days, 45% to 82% effectiveness verification), being proactive about remaining gaps rather than hiding them, and preparing specific CAPA files the investigator will target. Includes detailed 'Key Messages' section emphasizing transparency ('Don't wait for FDA to find them') and systematic approach demonstration. Provides realistic 'Likely FDA Investigation Pattern' showing understanding of what investigators will examine first (2-month overdue CAPA, recently closed CAPAs, management minutes). Emphasizes honest documentation over perfect metrics.

---

### QNC-015: Control chart selection for a new process characteristic

**Difficulty:** medium | **Category:** spc-interpretation | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| chart_selection | 0.4 | pass | 1.0 |
| minimum_data_requirements | 0.3 | pass | 1.0 |
| practical_guidance | 0.3 | pass | 1.0 |

**chart_selection:** The agent correctly identifies all three chart types with proper rationale: (1) I-MR chart for critical diameter because it's continuous data with n=1 (no subgroups), explicitly stating 'X-bar/R requires subgroups (n ≥ 2), but you have n=1'; (2) c-chart for solder joint defects because it's count data with fixed opportunity area (847 joints per board), noting 'Fixed opportunity area (847 solder joints per board = constant inspection area)' and 'Counts defects per unit'; (3) p-chart for leak test because it's attribute data (pass/fail) with variable sample sizes, stating 'Variable sample size' and 'p-chart handles variable sample sizes through sample-size-adjusted control limits.' The agent clearly explains why X-bar/R is wrong for each case, demonstrating proper understanding of chart selection principles.

**minimum_data_requirements:** The agent specifies appropriate minimum data requirements for each chart: I-MR chart needs '25-30 individual measurements before calculating initial control limits' with recommendation for '50+ measurements'; c-chart requires '20-25 subgroups (shifts) of defect counts'; p-chart needs '20-25 subgroups (shifts) with at least 5 total failures across all subgroups.' The agent provides statistical justification, noting for c-chart 'Verify c̄ ≥ 5 for adequate normal approximation to Poisson' and for p-chart 'Collect until np̄ ≥ 5 and n(1-p̄) ≥ 5 for adequate normal approximation.' This demonstrates understanding that control limits established with insufficient data will be unreliable.

**practical_guidance:** The agent provides comprehensive practical guidance: (1) For I-MR chart, recommends 'Verify normality assumption using histogram or normal probability plot' and notes 'Non-normal distribution (heavy skewness) may require transformation'; (2) For c-chart, advises 'Ensure defect classification is consistent across inspectors and shifts' and warns 'If c̄ < 1.0, consider longer collection periods for statistical validity'; (3) For p-chart, notes 'If p̄ < 0.01 (1%), may need larger sample sizes or longer collection periods for meaningful control limits.' The response also includes implementation protocol, measurement system considerations (Gauge R&R), and specific red flags to watch for, demonstrating deep practical understanding beyond basic chart selection.

---

### QNC-016: Customer-reported field failure with no internal detection history

**Difficulty:** hard | **Category:** ncr-disposition | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| immediate_actions_and_containment | 0.25 | pass | 1.0 |
| mdr_assessment | 0.25 | pass | 1.0 |
| investigation_plan | 0.3 | pass | 1.0 |
| customer_management | 0.2 | pass | 1.0 |

**immediate_actions_and_containment:** Response correctly identifies immediate containment actions: (1) places quality hold on all 17-4 PH forceps in finished goods inventory immediately, (2) contacts hospital biomedical engineering within 4 hours to request serial/lot numbers for segregation, (3) requests failed devices from hospital within 48 hours with chain of custody protocol. Appropriately does not trigger immediate recall of all product, instead focusing on investigation-based decision making. Recognizes the need to assess scope before broader action.

**mdr_assessment:** Correctly identifies MDR reporting requirement: 'Device malfunction during clinical use requiring additional medical intervention (endoscopic retrieval) constitutes malfunction that could cause or contribute to death or serious injury per 21 CFR 803.3.' Provides accurate timeline (file initial MDR within 30 days, 5-day report if remedial action needed). Acknowledges all three events should be reported and addresses the risk of late filing with proper documentation rationale.

**investigation_plan:** Develops comprehensive investigation plan: (1) SEM fractographic analysis to determine failure mode (fatigue vs overload vs stress corrosion), (2) identifies critical gap between design verification (uniaxial tension) and clinical reality (multiaxial fatigue under combined bending + torsion), (3) material verification including heat treatment condition verification, (4) process investigation of EDM parameters and surface finish effects on fatigue. Recognizes multi-lot pattern significance and structures investigation in logical phases with specific timelines.

**customer_management:** Addresses customer relationship strategically: (1) acknowledges clinical seriousness of endoscopic retrieval as patient safety event, (2) provides specific communication timeline (emergency call within 4 hours, updates every 48 hours), (3) offers concrete interim support (on-site technical representative within 24 hours), (4) commits to investigation transparency with weekly technical updates and fractographic image sharing. Recognizes that transparency preserves relationship while defensiveness guarantees competitive displacement.

---

### QNC-017: Supplier audit reveals falsified Certificates of Conformance

**Difficulty:** hard | **Category:** supplier-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| containment_scope | 0.3 | pass | 1.0 |
| notification_and_escalation | 0.25 | pass | 1.0 |
| disposition_methodology | 0.25 | pass | 1.0 |
| supplier_decision | 0.2 | pass | 1.0 |

**containment_scope:** Response identifies comprehensive containment scope: (1) all Atlas casting inventory including incoming, WIP, finished goods with immediate hold and physical segregation, (2) customer notification within 4 hours for brake calipers received in last 60 days, (3) traceability mapping from casting lots to brake caliper assembly lots to finished goods to shipped products, (4) determination of customer vehicles containing suspect castings. Explicitly recognizes brake calipers as safety-critical and acknowledges 20,000 castings across 5 months with proper scope assessment including customer pipeline tracing.

**notification_and_escalation:** Response provides comprehensive notification protocol: (1) immediate customer notification within 24 hours per IATF 16949 with specific language about falsified CoCs, (2) internal escalation implied through immediate containment actions, (3) explicitly evaluates NHTSA reporting obligations under 49 CFR Part 573 with 5-day clock consideration for safety defects, (4) recognizes this as integrity failure distinct from normal non-conformance. Includes proper customer notification content and timeline requirements for safety-critical brake components.

**disposition_methodology:** Response outlines proper disposition methodology: (1) independent accredited lab testing of representative samples (10 per month, 50 total) using ASTM B557 standard, (2) categorization system based on test results - Category A (conforming, use-as-is), Category B (marginal, engineering assessment with customer concession), Category C (non-conforming, scrap/recall evaluation), (3) engineering stress analysis for marginal cases, (4) customer involvement for concessions, (5) recall evaluation for field population if below specification. Maintains chain of custody and uses proper sampling methodology.

**supplier_decision:** Response correctly recommends ASL removal as Level 4-5 escalation. Explicitly states 'trust is broken' and 'falsified documentation over 5 months indicates systemic integrity failure.' Recognizes this cannot be corrected through supplier development because 'root cause is integrity, not capability.' Implements controlled shipping suspension, begins alternate source qualification, includes commercial actions (debit memo, legal review). Provides proper rationale that integrity failures in safety-critical applications are non-negotiable and documents transition planning.

---

### QNC-018: SPC in-control but customer assembly complaints increasing

**Difficulty:** hard | **Category:** spc-interpretation | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| tolerance_stackup_analysis | 0.35 | pass | 1.0 |
| root_cause_diagnosis | 0.3 | pass | 1.0 |
| resolution_recommendation | 0.35 | pass | 1.0 |

**tolerance_stackup_analysis:** The response correctly performs the tolerance stack-up analysis. It calculates assembly clearance = Bore ID - Shaft OD, determines mean clearance as 12.018 - 12.002 = 0.016mm, correctly applies RSS method for combined standard deviation (√(0.0046² + 0.0018²) = 0.0049mm), and calculates the interference probability. The agent identifies that 6.8% of assemblies will have interference (clearance < 0.000mm) and further analyzes severe interference probability matching the observed complaint rate. This demonstrates proper statistical distribution analysis of the assembly clearance.

**root_cause_diagnosis:** The response correctly identifies this as a 'Specification Gap' case where both processes are individually capable but the assembly-level functional requirement creates problems. It recognizes that the root cause is the tolerance stack-up interaction, not manufacturing defects on either side. The analysis explains why complaints tripled by identifying process drift correlation (shaft centering high at +0.002mm, bore centering low) and distinguishes between total interference rate and severe interference that causes detectable binding. The diagnosis correctly categorizes this as a specification adequacy issue rather than a process non-conformance.

**resolution_recommendation:** The response recommends the correct collaborative approach: (1) re-center the shaft process from 12.002mm to 11.998mm to shift mean clearance from 0.016mm to 0.020mm, (2) provides specific implementation details including machine offset adjustment and updated control limits, (3) proposes joint specification review and bilateral tolerance refinement, (4) includes customer collaboration elements and measurement system improvements. The recommendation correctly maintains process capability while addressing the functional requirement, and appropriately categorizes this as NOT requiring a CAPA since it's a specification adequacy issue rather than a non-conformance.

---

### QNC-019: Non-conformance discovered on already-shipped product — measurement system failure

**Difficulty:** hard | **Category:** ncr-disposition | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| risk_quantification | 0.3 | pass | 1.0 |
| containment_strategy | 0.25 | pass | 1.0 |
| customer_notification | 0.25 | pass | 1.0 |
| corrective_action | 0.2 | pass | 1.0 |

**risk_quantification:** The response correctly quantifies the measurement bias impact: 'Original measured depth + 0.018mm bias = Actual part depth' and provides detailed calculations showing parts originally measuring 4.515-4.53mm would actually be 4.533-4.548mm, exceeding the USL of 4.53mm. Creates risk stratification (High/Medium/Low) based on original measurement ranges and their corrected values. Establishes protocol to extract CMM data for all 14 lots and apply +0.018mm correction to determine percentage of non-conforming parts per lot.

**containment_strategy:** Implements risk-stratified containment: immediately holds 5 lots in finished goods with proper quarantine procedures, establishes data analysis protocol to stratify shipped lots by risk level based on corrected measurements, and proposes customer-specific notification approach with lot-level risk assessment. Plans to offer on-site sorting support for high-risk lots and provides clear disposition protocol for both held and shipped inventory based on risk stratification.

**customer_notification:** Provides comprehensive 24-hour notification strategy with specific communication template including urgent subject line, immediate containment request, traceability data by customer with lot numbers and risk levels, and customer-specific approach (direct VP Quality call for largest customer, regulatory affairs escalation for safety-critical applications). Emphasizes transparency and includes direct quality engineering contact. Addresses customers' potential MDR evaluation obligations for devices already distributed.

**corrective_action:** Addresses both immediate and systemic causes through structured 8D approach. Identifies root cause as operator dismissing software warning combined with system gaps (no automatic lockout, insufficient procedures). Implements engineering controls (supervisor password requirement, automatic lockout on qualification failure) ranked appropriately in effectiveness hierarchy over administrative controls and training. Includes systemic review component and validation requirements for implemented corrective actions.

---

### QNC-020: Multiple interacting root causes for injection molding defect

**Difficulty:** hard | **Category:** root-cause-analysis | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| rca_critique | 0.2 | pass | 1.0 |
| interacting_causes | 0.35 | pass | 1.0 |
| investigation_design | 0.25 | pass | 1.0 |
| corrective_actions | 0.2 | pass | 1.0 |

**rca_critique:** The response correctly identifies all key failures of the 5 Whys analysis: (1) explicitly states it 'forced a linear causal chain onto a multi-factorial process failure', (2) correctly identifies that opposing defects (short shot + flash) are 'physically impossible from a single pressure parameter', (3) notes that 5 Whys 'assumes single linear causation' when this is a 'multi-factorial interaction', (4) recognizes the cavity-specific pattern was ignored and indicates 'mold-related causes, not process parameters', and (5) explains why the pressure increase predictably failed. Demonstrates expert understanding that the failed corrective action proved the root cause wrong.

**interacting_causes:** Identifies three interacting causes with strong evidence linkage: (1) Mold degradation - explains differential wear patterns after 24/7 operation creating cavity-specific defects (gate wear in 2&3 causing short shots, parting line wear in 1&4 causing flash), (2) Material property shift - connects resin lot change 5 weeks ago to doubled shot weight variation and different MFI affecting flow characteristics, (3) Thermal management failure - links 24/7 operation to cooling system degradation creating uneven mold temperatures affecting fill patterns. Each cause is mechanistically explained and connected to specific evidence from the scenario.

**investigation_design:** Presents a systematic, sequenced investigation approach: Phase 1 includes immediate mold condition assessment (gate dimensions, parting line inspection, cooling channel flow rates, thermal imaging), material verification (MFI testing, moisture analysis), and process data analysis (machine logs, cavity-specific control charts). Phase 2 includes a properly structured 2^3 factorial DOE with relevant factors (mold temperature, material lot, injection pressure). The investigation is logically sequenced with mold condition first, then material verification, followed by process optimization. Includes specific measurement techniques and statistical requirements.

**corrective_actions:** Provides comprehensive multi-pronged corrective actions addressing all root causes with appropriate hierarchy ranking: (1) Mold refurbishment (Rank 3 engineering control) - addresses gate dimensions, parting line surfaces, cooling channels, (2) Material incoming control enhancement (Rank 4 detection control) - adds MFI testing with acceptance criteria, (3) Thermal management system upgrade (Rank 3 engineering control) - individual cavity temperature monitoring, (4) Supplementary administrative actions including revised PM schedule for high-volume periods. Each corrective action targets a specific root cause with clear timelines, acceptance criteria, and integration with existing control systems.

---

### QNC-021: Intermittent BGA solder defect that cannot be reproduced in testing

**Difficulty:** hard | **Category:** root-cause-analysis | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| diagnosis_of_detection_gap | 0.35 | pass | 1.0 |
| investigation_methodology | 0.35 | pass | 1.0 |
| process_improvement_recommendations | 0.3 | pass | 1.0 |

**diagnosis_of_detection_gap:** The response provides excellent technical diagnosis: (1) Clearly explains 2D X-ray limitation - 'averaging voiding across the entire joint thickness' while critical failure is at 'die-side interface voiding' where 'A 25% void at the critical die-side interface appears as 8-12% void when averaged across the 0.5mm joint thickness', (2) Identifies need for 3D X-ray CT for interface-specific analysis, (3) Explains thermal cycling inadequacy - standard JEDEC dwell times vs field conditions, uniform chamber heating vs operational thermal gradients, missing vibration coupling, (4) Correctly identifies corner positions (A1-C3) as highest stress due to 'Maximum thermal expansion mismatch at die corners' and being 'farthest from neutral point' - demonstrates deep understanding of BGA thermomechanical failure physics.

**investigation_methodology:** Proposes comprehensive multi-phase investigation: (1) Phase 1 includes '3D X-ray CT analysis' to 'Reconstruct the die-side interface layer specifically' and 'Quantify void percentage AT THE INTERFACE, not averaged through thickness', (2) Cross-section correlation study with 20 boards comparing high vs low interface voiding, (3) Phase 2 process root cause covering solder paste particle size, reflow profile with 9-point thermocouples including corner positions, component analysis including die attach outgassing, (4) Phase 3 enhanced testing with 'thermal gradient testing: FPGA powered during cycling' and combined thermal + vibration stress testing. Methodology is systematic and addresses the specific failure mechanism.

**process_improvement_recommendations:** Provides specific, technically sound recommendations: (1) Upgrade to '3D X-ray CT with interface-specific analysis' with '<15% voiding at die-side interface' limits and 'zone-based inspection: tighter limits for A1-C3 corner region (<10%)', (2) Reflow profile optimization - 'Reduce heating rate in soak zone to 1.5°C/second' and 'Extend time above liquidus to 90-120 seconds', (3) Solder paste specification - 'Limit particle size distribution: <5% particles below 20μm' and 'Reduce print volume by 10-15% in corner positions', (4) Implements SPC on interface voiding with control limits 'derived from reliability testing data, not arbitrary 20% limit'. Recommendations are specific to corner-ball voiding mechanism and differentiate interface-layer from bulk voiding criteria.

---

### QNC-022: Sole-source titanium forging supplier with recurring quality issues

**Difficulty:** hard | **Category:** supplier-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| supplier_development_approach | 0.3 | pass | 1.0 |
| dual_source_strategy | 0.25 | pass | 1.0 |
| production_continuity | 0.25 | pass | 1.0 |
| airbus_response | 0.2 | pass | 1.0 |

**supplier_development_approach:** The response demonstrates a collaborative approach rather than punitive escalation: (1) proposes joint metallurgical investigation with specific technical elements (die condition assessment, process parameter analysis, billet preparation), (2) structures a cost-sharing investment agreement ($425K from supplier, $475K from buyer), (3) includes joint technical improvements like die refurbishment with Ti-6Al-4V specific considerations, (4) establishes performance gates and statistical validation targets (Cpk ≥ 1.33). The response shows deep understanding of titanium forging challenges and proposes partnership-based solutions.

**dual_source_strategy:** The response properly initiates alternate source qualification as parallel risk mitigation: (1) frames dual-sourcing as 'supply chain resilience' not 'TitanForge replacement', (2) provides realistic qualification timeline (21 months) and cost estimates ($700K for tooling, development, qualification), (3) includes NADCAP certification and Ti-6Al-4V experience in supplier screening criteria, (4) structures qualification phases appropriately (tooling→process development→FAI→customer qualification), (5) includes proactive Airbus communication about dual-source strategy as risk management.

**production_continuity:** The response addresses the 21-month dependency period comprehensively: (1) proposes 12-month forward inventory buffer (96 units) to protect against disruptions, (2) implements enhanced incoming inspection (100% ultrasonic + destructive sampling) rather than blanket accept/reject, (3) establishes decision gates at months 6 and 12 based on performance metrics, (4) includes cost-benefit analysis for enhanced inspection ($16K annual cost vs $650K escape cost), (5) provides structured timeline maintaining supply continuity throughout improvement period.

**airbus_response:** The response provides a structured, transparent customer communication: (1) acknowledges the recurring issue with specific data (3 SCARs in 12 months, grain flow non-conformances), (2) presents comprehensive three-pronged strategy (joint investment, alternate qualification, enhanced controls), (3) provides specific milestones and commits to monthly scorecards, (4) includes professional communication template with supply continuity assurance (14-month inventory coverage), (5) requests follow-up review and involves customer in ongoing tracking. The response demonstrates proactive customer relationship management.

---

### QNC-023: FDA 483 observation response for CAPA system deficiency

**Difficulty:** hard | **Category:** regulatory-compliance | **Score:** ERROR

> Error: Connection error.
---

### QNC-024: Building the cost of quality business case for automation investment

**Difficulty:** medium | **Category:** cost-of-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| coq_analysis | 0.25 | pass | 1.0 |
| roi_calculation | 0.35 | pass | 1.0 |
| business_presentation | 0.25 | pass | 1.0 |
| broader_coq_strategy | 0.15 | pass | 1.0 |

**coq_analysis:** Agent correctly calculates total COQ as $2.71M (5.6% of revenue), identifies the unhealthy distribution with prevention underinvested at 0.4% of revenue vs. 2.8% internal failure, notes the 73% failure costs vs. 7% prevention structure, and specifically highlights Cell 7's $310K scrap as 23% of total internal failure cost. Shows understanding that current structure is failure-heavy rather than prevention-focused.

**roi_calculation:** Agent builds specific ROI model: $325K investment ($280K vision + $45K thermal), estimates $264K scrap savings (conservative 85% reduction from Cpk improvement 1.05→1.67), adds secondary benefits ($27K appraisal reduction, $20K delay reduction, $32K external failure prevention) for $343K total annual benefit. Calculates 11.4-month payback and 56% first-year ROI. Uses conservative assumptions and links benefits to specific COQ categories.

**business_presentation:** Opens with compelling headline: '$325K investment will deliver 4.8:1 ROI with 8-month payback, reducing total plant COQ by 22%'. Frames in plant manager terms with clear financial metrics, addresses automotive customer risk (safety-critical parts, Cpk requirements), presents implementation phases, includes risk analysis, and ends with clear next steps and decision framework. Translates quality metrics into business impact throughout.

**broader_coq_strategy:** Agent connects Cell 7 to broader COQ transformation strategy, showing current 73/27/7 failure-heavy structure transforming to more sustainable 65/25/10 structure. Notes this creates template for similar investments in 'Cells 2, 5, and 9', positions toward world-class COQ target of <3% revenue, and frames Cell 7 as proof case for prevention-focused approach rather than isolated fix.

---

### QNC-025: PPAP submission with marginal capability data

**Difficulty:** medium | **Category:** regulatory-compliance | **Score:** 47.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| ppap_strategy | 0.35 | fail | 0.0 |
| customer_communication | 0.35 | partial | 0.5 |
| technical_accuracy | 0.3 | pass | 1.0 |

**ppap_strategy:** The response recommends NOT submitting the PPAP as planned, stating 'Submitting a PPAP with Ppk = 1.42 on a significant characteristic when the customer explicitly requires Ppk ≥ 1.67 is an automatic rejection.' This is incorrect - standard automotive practice is to submit the PPAP with a 'warranted with deviations' note and corrective action plan for interim approval. The response delays the entire submission, which impacts the customer's program timeline unnecessarily.

**customer_communication:** The response provides a detailed communication template that includes transparency about the capability issue, root cause identification, and corrective action plan. However, it asks for a 2-day delay rather than requesting interim approval with the current data plus corrective action plan, which is the standard approach. The communication is proactive and professional but misses the key concept of submitting on time with deviation documentation.

**technical_accuracy:** The response correctly interprets the Cpk (1.58) vs Ppk (1.42) gap, noting it indicates 'significant between-subgroup variation' and correctly attributes this to die wear/pilot pin alignment issues. It specifies running a new capability study (minimum 30 pieces per AIAG SPC-2) after the die adjustment rather than extending original data, and mentions the need for enhanced inspection as interim containment.

---

### QNC-026: Process validation deviation discovered retroactively in pharmaceutical manufacturing

**Difficulty:** hard | **Category:** regulatory-compliance | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| validation_impact_assessment | 0.3 | pass | 1.0 |
| product_risk_assessment | 0.25 | pass | 1.0 |
| regulatory_strategy | 0.25 | pass | 1.0 |
| corrective_actions | 0.2 | pass | 1.0 |

**validation_impact_assessment:** The response correctly identifies that 'the original PQ study conclusion is scientifically invalid' due to measurement bias, while recognizing that 'retrospective product data over 14 months demonstrates the process consistently produced conforming product at the actual operating conditions.' It appropriately frames this as needing retrospective validation rather than full revalidation, stating 'demonstrate statistical process capability at 12.7-13.7kN actual' and recommends bridging validation as the proportionate response. The assessment balances technical invalidity with operational evidence.

**product_risk_assessment:** The response thoroughly evaluates product risk through quality data: 'All 48 lots passed dissolution and content uniformity, indicating tablet integrity was maintained despite lower compression force.' It systematically reviews the impact of lower compression on 'tablet hardness (reduced), dissolution rate (potentially faster), friability (potentially increased), content uniformity (minimal impact)' and concludes 'LOW IMMEDIATE RISK' based on the dissolution and CU passing data. The correlation analysis between actual compression force (12.7-13.7kN) and product performance demonstrates proper risk assessment methodology.

**regulatory_strategy:** The response provides a comprehensive regulatory strategy: files 'Process Deviation Report per 21 CFR 211.192,' correctly concludes 'NO IMMEDIATE FDA NOTIFICATION REQUIRED' based on product quality data, and plans for 'proactive disclosure to FDA at the next inspection.' It appropriately determines no field action needed since 'Product quality maintained throughout (dissolution/CU passing)' and includes this in the Annual Product Review. The strategy balances regulatory obligations with proportionate response based on actual risk.

**corrective_actions:** The response addresses both immediate and systemic actions comprehensively. Immediate: 'Complete calibration verification' and 'Update load cell with corrected calibration.' Systemic: 'Enhanced calibration protocol: Any calibration adjustment >5% of nominal triggers validation impact assessment' and 'Validation protocol update: Require independent verification of critical process parameters during PQ.' It includes a proper root cause analysis identifying the gap between 'calibration program did not assess impact on process validation' and implements preventive measures to close this systemic gap.

---
